Orchid Pharma Limited (ORCHPHARMA) — Corporate Action

📢 Key Event
NCLT sanctions merger of Dhanuka Laboratories into Orchid Pharma

🔄 What Changed
Scheme of amalgamation approved, transferring Dhanuka Laboratories to Orchid Pharma

💡 Investor Takeaway
Shareholders of Dhanuka Laboratories will receive shares in the combined entity as per the merger scheme.

Orchid Pharma announced that the National Company Law Tribunal approved the merger of Dhanuka Laboratories into Orchid Pharma on June 5, 2026, effective immediately, transferring assets and liabilities to the combined entity.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ORCHPHARMA ✨ Ask AI About This

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

💡 Ask AI about this filing

"How does this affect ORCHPHARMA margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

🔥 Also filed on 5 June 2026

CEINSYS Ceinsys Tech Limited Announcement INDOBORAX Indo Borax & Chemicals Limited Announcement CONSOFINVT Consolidated Finvest & Holdings Limited Announcement NIRAJISPAT Niraj Ispat Industries Limited Announcement RUSHABEAR Rushabh Precision Bearings Limited Announcement PTC PTC India Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day